Globus Medical, Inc. (GMED) Financial Statements

Executive TeamFinancials
SegmentsShareholders

Globus Medical financial statements at a glance

Globus Medical reported revenue of $2.94 billion for fiscal year 2025 (ended December 31, 2025), up 16.7% from fiscal year 2024. Net income was $537.87 million, a net margin of 18.3%, and diluted earnings per share were $3.92.

At the end of fiscal year 2025 it had total assets of $5.30 billion, total liabilities of $729.51 million and shareholders' equity of $4.57 billion, with cash and short-term investments of $557.24 million and total debt of $118.66 million.

Its operations brought in $753.45 million of cash; capital spending was $174.43 million, leaving free cash flow of $579.02 million.

The tables below show the income statement, balance sheet and cash flow statement; the key figures of the last 5 fiscal years are at the bottom of the page.

Figures from company filings, in USD; latest fiscal year ended December 31, 2025.

GMED logo

Globus Medical, Inc.

GMEDUnited States
Healthcare
USD (Local)

Income Statement

Annual • USD

Total Revenue
2.94B
Prev Year: 2.52B
YoY: +16.7%
Operating Revenue
2.94B
Prev Year: 2.52B
YoY: +16.7%
Total Unusual Items
57.32M
Prev Year: -97.00M
YoY: +159.1%
Normalized EBITDA
756.71M
Prev Year: 570.72M
YoY: +32.6%
Tax Rate for Calcs
0.111
Prev Year: 0
Tax Effect of Unusual Items
6.36M
Prev Year: -14.25M
YoY: +144.6%
Gain on Sale of Securities
-3.01M
Prev Year: -43.28M
YoY: +93.1%
Total Other Finance Cost
-7.14M
Prev Year: 4.19M
YoY: -270.5%
Cost of Revenue
957.80M
Prev Year: 1.04B
YoY: -7.5%
Gross Profit
1.98B
Prev Year: 1.48B
YoY: +33.5%
Operating Expense
1.44B
Prev Year: 1.26B
YoY: +14.2%
Selling General and Administrative
1.18B
Prev Year: 981.05M
YoY: +20.1%
Research and Development
147.25M
Prev Year: 163.75M
YoY: -10.1%
Depreciation Amortization Depletion
118.19M
Prev Year: 119.37M
YoY: -1.0%
Depreciation and amortization
118.19M
Prev Year: 119.37M
YoY: -1.0%
Amortization
118.19M
Prev Year: 119.37M
YoY: -1.0%
Amortization of Intangibles
118.19M
Prev Year: 119.37M
YoY: -1.0%
Operating Income
537.19M
Prev Year: 219.70M
YoY: +144.5%
Net Non Operating Interest Income Expense
7.14M
Prev Year: -4.19M
YoY: +270.5%
Other Income Expense
60.74M
Prev Year: -94.79M
YoY: +164.1%
Special Income Charges
60.33M
Prev Year: -53.71M
YoY: +212.3%
Restructuring and Mergers Acquisition
-60.33M
Prev Year: 53.40M
YoY: -213.0%
Other Non-operating Income (expense)
3.41M
Prev Year: 2.21M
YoY: +54.8%
Pre-tax Income
605.07M
Prev Year: 120.72M
YoY: +401.2%
Provision for Income Taxes
67.20M
Prev Year: 17.74M
YoY: +278.8%
Net Income Common Stockholders
537.87M
Prev Year: 102.98M
YoY: +422.3%
Net Income
537.87M
Prev Year: 102.98M
YoY: +422.3%
Net Income Including Non-Controlling Interests
537.87M
Prev Year: 102.98M
YoY: +422.3%
Net Income from Continuing Operations
537.87M
Prev Year: 102.98M
YoY: +422.3%
Diluted NI Available to Com Stockholders
537.87M
Prev Year: 102.98M
YoY: +422.3%
Basic EPS
3.98
Prev Year: 0.76
YoY: +423.7%
Diluted EPS
3.92
Prev Year: 0.75
YoY: +422.7%
Weighted Average Shares (basic)
135.22M
Prev Year: 135.73M
YoY: -0.4%
Weighted Average Shares (diluted)
137.06M
Prev Year: 137.86M
YoY: -0.6%
Total Operating Income as Reported
479.82M
Prev Year: 165.99M
YoY: +189.1%
Total Expenses
2.40B
Prev Year: 2.30B
YoY: +4.4%
Net Income from Continuing and Discontinued Operation
537.87M
Prev Year: 102.98M
YoY: +422.3%
Normalized Income
486.91M
Prev Year: 185.73M
YoY: +162.2%
Net Interest Income
7.14M
Prev Year: -4.19M
YoY: +270.5%
Interest Expense
-
EBIT
537.19M
Prev Year: 219.70M
YoY: +144.5%
EBITDA
814.03M
Prev Year: 473.73M
YoY: +71.8%
Reconciled Cost of Revenue
799.15M
Prev Year: 900.83M
YoY: -11.3%
Reconciled Depreciation
276.84M
Prev Year: 254.02M
YoY: +9.0%
Net Income from Continuing Operation Net Minority Interest
537.87M
Prev Year: 102.98M
YoY: +422.3%
Total Unusual Items Excluding Goodwill
57.32M
Prev Year: -97.00M
YoY: +159.1%
Values in USD

Globus Medical key figures by fiscal year

FY2025FY2024FY2023FY2022FY2021
Revenue$2.9B$2.5B$1.6B$1.0B$958.1M
Gross profit$2.0B$1.5B$1.0B$759.1M$718.9M
Operating income$537.2M$219.7M$201.9M$236.3M$194.9M
Net income$537.9M$103.0M$122.9M$190.2M$149.2M
Diluted EPS$3.92$0.75$1.07$1.85$1.44
Total assets$5.3B$5.3B$5.1B$2.1B$2.0B
Total liabilities$729.5M$1.1B$1.1B$229.8M$215.9M
Shareholders' equity$4.6B$4.2B$4.0B$1.8B$1.7B
Cash and short-term investments$557.2M$890.1M$517.8M$446.1M$443.4M
Total debt$118.7M$537.2M$520.4M$6.0M–
Operating cash flow$753.4M$520.6M$243.5M$178.5M$276.3M
Capital spending$174.4M$115.4M$78.3M$74.0M$56.9M
Free cash flow$579.0M$405.2M$165.2M$104.4M$219.4M

In USD. Fiscal years as reported by the company; statements on this page go back to fiscal year 2014.

Questions and answers

What was Globus Medical's revenue in fiscal year 2025?

$2.94 billion, up 16.7% from $2.52 billion in fiscal year 2024.

How much profit does Globus Medical make?

Globus Medical reported net income of $537.87 million for fiscal year 2025 (18.3% of revenue); operating income was $537.19 million.

How much cash and debt does Globus Medical have?

At the end of fiscal year 2025: cash and short-term investments of $557.24 million and total debt of $118.66 million.

What is Globus Medical's free cash flow?

$579.02 million in fiscal year 2025 (operating cash flow of $753.45 million minus capital spending of $174.43 million).

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube